Epitomee Med (EPIT) Stock Statistics & Valuation Metrics

Epitomee Med has a market cap or net worth of 242.55M. The enterprise value is 1.20B.

Epitomee Med has 29,816,158 shares outstanding. The number of shares has decreased by -2.65% in one year.

Epitomee Med’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -17.45%.

The current PE Ratio of Epitomee Med is -19.42. Epitomee Med’s PEG ratio is 0.00.

In the last 12 months, Epitomee Med had revenue of 10.00M and earned -5.68M in profits. Earnings per share was -0.19.

In the last 12 months, operating cash flow was -2.25B and capital expenditures -783.13M, giving a free cash flow of -3.04B billion.

Epitomee Med pays an annual dividend of ―, resulting in a dividend yield of ―

Epitomee Med upcoming earnings date is ―, TBA Not Confirmed.

Epitomee Med as a current ratio of 17.92, with Debt / Equity ratio of 6.25%

In the past 12 months, Epitomee Med has paid 0.00 in taxes.

Epitomee Med EV to EBITDA ratio is -19.79, with an EV/FCF ratio of -8.22.

Epitomee Med has 29.14M in cash and marketable securities with 4.22M in debt, giving a net cash position of -24.92M billion.

Gross margin is 0.00%, with operating margin of -67.63%, and net profit margin of -56.82%.

The average price target for Epitomee Med is ―, which is 11.43% higher than the current price. The consensus rating is ―